APRIL GRADY: Open Payments
NPI 1275395949 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 30 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $184 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| Amgen Inc. | 4 | $60 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Ardelyx, Inc. | 3 | $58 |
| Globus Medical, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $44 |
| Lilly USA, LLC | 3 | $42 |
| ABBVIE INC. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
Products named: Kerendia, OTEZLA, TRELEGY ELLIPTA, IBSRELA, Senza, Ozempic, MOUNJARO, LINZESS.
Industry payments across NC — which companies pay providers there.
